tradingkey.logo

INmune Bio Inc <INMB.OQ> expected to post a loss of 47 cents a share - Earnings Preview

ReutersMay 5, 2025 11:18 AM
  • INmune Bio Inc INMB.OQ INMB.O is expected to show a fall in quarterly revenue when it reports results on May 7 (estimated) for the period ending March 31 2025

  • ​LSEG's mean analyst estimate for INmune Bio Inc is for a loss of 47 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts had risen by about 3.6% in the last three months. ​

  • Wall Street's median 12-month price target for INmune Bio Inc is $23.00​, above​ its last closing price of $7.76. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

-0.54

-0.40

Beat

25.9

Sep. 30 2024

-0.48

-0.50

-0.60

Missed

-20.8

Jun. 30 2024

-0.63

-0.63

-0.50

Beat

20.6​

Mar. 31 2024

-0.53

-0.53

-0.61

Missed

-14

​​Dec. 31 2023

-0.44

-0.47

Missed

-6.8

Sep. 30 2023

-0.39

-0.39

-0.48

Missed

-21.5​

Jun. 30 2023

-0.39

-0.40

-0.36

Beat

9.2

Mar. 31 2023

-0.02

-0.02

-0.36

Missed

-1,700

This summary was machine generated May 5 at 11:18 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI